OpenVSafe by OpenVAERS
Search V-safe

B5L-76046-14001

6 vaccinations 10 coded responses 56 check-ins 10 free-text entries 0 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
857 / AZ
Registered
2021-01-29
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-28
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-29
    Registered in v-safe
  3. 2021-01-29
    Survey response — days 1–6 daily, dose 1
    MedDRA: Mast cell activation syndrome — Feeling: Poor · Site: Pain, Redness, Swelling, Itching · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities
    Free text: I have Mast Cell Activation Disorder
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-01-31
    Survey response — days 1–6 daily, dose 1
    MedDRA: Mast cell activation syndrome — Feeling: Fair · Site: Pain, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site
    Free text: Mast Cell activation disorder
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-02-01
    Survey response — days 1–6 daily, dose 1
    MedDRA: Mast cell activation syndrome — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site
    Free text: I have Mast Cell Activation Syndrome
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-02-02
    Survey response — days 1–6 daily, dose 1
    MedDRA: Mast cell activation syndrome — Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site
    Free text: I have Mast Cell Activation Disorder
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-02-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  8. 2021-02-04
    Health check-in — day 7, dose 1
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness
    Adult check-in
  9. 2021-02-11
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  10. 2021-02-18
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-02-19
    Dose 2 — Pfizer-BioNTech
  12. 2021-02-25
    Survey response — days 1–6 daily, dose 2
    MedDRA: Pre-existing disease — Feeling: Fair · Site: Redness, Itching · Diarrhea, Rash, not including the immediate area around the injection site
    Free text: Mast Cell Activation Disorder
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-02-26
    Survey response — day 7, dose 2
    MedDRA: Mass, Mast cell activation syndrome — Feeling: Fair · Site: Itching · Fatigue or tiredness, Rash, not including the immediate area around the injection site
    Free text: Mast cell activation disorder
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-03-05
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-03-12
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-03-19
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-03-27
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-04-02
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-05-21
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-08-20
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-08-22
    Dose 3 — Pfizer-BioNTech
  22. 2021-09-30
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  23. 2021-10-03
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  24. 2021-11-21
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  25. 2022-02-20
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  26. 2022-02-21
    Dose 4 — Pfizer-BioNTech
  27. 2022-02-21
    Health check-in — day 0, dose 4
    Feeling: Fair · Site: Pain, Redness, Itching · Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  28. 2022-02-22
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Site: Pain, Swelling, Itching · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  29. 2022-02-23
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  30. 2022-02-24
    Survey response — days 1–6 daily, dose 4
    MedDRA: Adverse reaction, Pre-existing disease, Self-medication — Feeling: Good · Site: Pain · Fatigue or tiredness
    Free text: Systemic mast cell reactions (rejecting formerly healed piercings) but I did start to wean off my prophylactic Benadryl today
    MedDRA releases: 2024-11 · check-in free text available
  31. 2022-02-25
    Survey response — days 1–6 daily, dose 4
    MedDRA: Condition aggravated, Pre-existing disease, Self-medication — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness
    Free text: systemic mast cell symptoms (rejection of previously healed piercings, old wounds reopening); trying to wean off Benadryl; I have mast cell activation disorder
    MedDRA releases: 2024-11 · check-in free text available
  32. 2022-02-26
    Survey response — days 1–6 daily, dose 4
    MedDRA: Condition aggravated, Pre-existing disease, Self-medication — Feeling: Fair · Headache, Fatigue or tiredness
    Free text: Continuing mast cell systemic symptoms- rejecting previously healed piercings, old wounds reopening; I have mast cell activation disorder and have been weaning off my prophylactic Benadryl the last few days
    MedDRA releases: 2024-11 · check-in free text available
  33. 2022-02-27
    Survey response — days 1–6 daily, dose 4
    MedDRA: Mast cell activation syndrome, Self-medication — Feeling: Fair · Fatigue or tiredness
    Free text: systemic mast cell activation symptoms- rejecting previously healed piercings (I have mast cell activation disorder and have been trying to wean off my prophylactic Benadryl)
    MedDRA releases: 2024-11 · check-in free text available
  34. 2022-02-28
    Health check-in — day 7, dose 4
    Feeling: Good · None
    Adult check-in
  35. 2022-03-07
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  36. 2022-03-14
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  37. 2022-03-21
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  38. 2022-03-28
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  39. 2022-04-05
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  40. 2022-05-23
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  41. 2022-08-23
    Health check-in — 6 months, dose 4
    Feeling: Good
    Adult check-in
  42. 2022-09-08
    Dose 5 — Pfizer-BioNTech
  43. 2022-09-14
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · None
    Adult check-in
  44. 2022-09-17
    Health check-in — day 7, dose 5
    Feeling: Good · None
    Adult check-in
  45. 2022-09-22
    Health check-in — day 14, dose 5
    Feeling: Good
    Adult check-in
  46. 2022-09-29
    Health check-in — day 21, dose 5
    Feeling: Good
    Adult check-in
  47. 2022-10-06
    Health check-in — day 28, dose 5
    Feeling: Good
    Adult check-in
  48. 2022-10-13
    Health check-in — day 35, dose 5
    Feeling: Good
    Adult check-in
  49. 2022-10-20
    Health check-in — day 42, dose 5
    Feeling: Good
    Adult check-in
  50. 2022-12-08
    Health check-in — 3 months, dose 5
    Feeling: Good
    Adult check-in
  51. 2023-03-06
    Dose 6 — Pfizer-BioNTech
  52. 2023-03-09
    Health check-in — 6 months, dose 5
    Feeling: Fair
    Adult check-in
  53. 2023-03-09
    Health check-in — days 1–6 daily, dose 6
    Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  54. 2023-03-10
    Health check-in — days 1–6 daily, dose 6
    Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  55. 2023-03-11
    Health check-in — days 1–6 daily, dose 6
    Feeling: Fair · Headache, Fatigue or tiredness
    Adult check-in
  56. 2023-03-12
    Health check-in — days 1–6 daily, dose 6
    Feeling: Fair · Headache, Fatigue or tiredness
    Adult check-in
  57. 2023-03-13
    Health check-in — day 7, dose 6
    Feeling: Fair · Headache, Fatigue or tiredness
    Adult check-in
  58. 2023-03-20
    Health check-in — day 14, dose 6
    Feeling: Good
    Adult check-in
  59. 2023-03-27
    Health check-in — day 21, dose 6
    Feeling: Good
    Adult check-in
  60. 2023-04-03
    Health check-in — day 28, dose 6
    Feeling: Good
    Adult check-in
  61. 2023-04-10
    Health check-in — day 35, dose 6
    Feeling: Good
    Adult check-in
  62. 2023-04-17
    Health check-in — day 42, dose 6
    Feeling: Good
    Adult check-in
  63. 2023-06-05
    Health check-in — 3 months, dose 6
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-28Pfizer-BioNTech
22021-02-19Pfizer-BioNTech
32021-08-22Pfizer-BioNTech No
42022-02-21Pfizer-BioNTech No
52022-09-08Pfizer-BioNTech No
62023-03-06Pfizer-BioNTech No

Free text

Release 3 — days 1–6 daily, dose 1

2021-01-29

Systemic reaction (other): I have Mast Cell Activation Disorder

2021-01-31

Systemic reaction (other): Mast Cell activation disorder

2021-02-01

Systemic reaction (other): I have Mast Cell Activation Syndrome

2021-02-02

Systemic reaction (other): I have Mast Cell Activation Disorder

Release 4 — days 1–6 daily, dose 2

2021-02-25

Systemic reaction (other): Mast Cell Activation Disorder

Release 4 — day 7, dose 2

2021-02-26

Systemic reaction (other): Mast cell activation disorder

Release 11 — days 1–6 daily, dose 4

2022-02-24

Systemic reaction (other): Systemic mast cell reactions (rejecting formerly healed piercings) but I did start to wean off my prophylactic Benadryl today

2022-02-25

Systemic reaction (other): systemic mast cell symptoms (rejection of previously healed piercings, old wounds reopening); trying to wean off Benadryl; I have mast cell activation disorder

2022-02-26

Systemic reaction (other): Continuing mast cell systemic symptoms- rejecting previously healed piercings, old wounds reopening; I have mast cell activation disorder and have been weaning off my prophylactic Benadryl the last few days

2022-02-27

Systemic reaction (other): systemic mast cell activation symptoms- rejecting previously healed piercings (I have mast cell activation disorder and have been trying to wean off my prophylactic Benadryl)

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SROAdverse reaction · · ✓
SROCondition aggravated · · ✓
SROMass ✓ ✓ ○
SROMast cell activation syndrome ✓ ✓ ✓
SROPre-existing disease ✓ ✓ ✓
SROSelf-medication · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release